68 related articles for article (PubMed ID: 21406344)
1. Reduction in cisplatin genotoxicity (micronucleus formation) in non target cells of mice by protransfersome gel formulation used for management of cutaneous squamous cell carcinoma.
Gupta V; Agrawal RC; Trivedi P
Acta Pharm; 2011 Mar; 61(1):63-71. PubMed ID: 21406344
[TBL] [Abstract][Full Text] [Related]
2. Localized delivery of cisplatin for the effective management of squamous cell carcinoma from protransfersome formulation.
Gupta V; Karthikeyan C; Trivedi P
Arch Pharm Res; 2012 May; 35(5):851-9. PubMed ID: 22644852
[TBL] [Abstract][Full Text] [Related]
3. Development of novel topical drug delivery system containing cisplatin and imiquimod for dual therapy in cutaneous epithelial malignancy.
Gupta V; Dhote V; Paul BN; Trivedi P
J Liposome Res; 2014 Jun; 24(2):150-62. PubMed ID: 24328725
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo localization and permeation of cisplatin from novel topical formulations through excised pig, goat, and mice skin and in vitro characterization for effective management of skin-cited malignancies.
Gupta V; Trivedi P
Artif Cells Nanomed Biotechnol; 2015; 43(6):373-82. PubMed ID: 24628359
[TBL] [Abstract][Full Text] [Related]
5. High-mobility group A1 (HMGA1) protein expression correlates with cisplatin-induced cell death in squamous cell carcinoma of skin.
Sharma A; Ray R; Rajeswari MR
Cancer Invest; 2010 May; 28(4):340-9. PubMed ID: 19916743
[TBL] [Abstract][Full Text] [Related]
6. Topical delivery of fluorescence (6-Cf) labeled and radiolabeled (99m-Tc) cisplatin and imiquimod by a dual drug delivery system.
Gupta V; Chuttani K; Mishra AK; Trivedi P
J Labelled Comp Radiopharm; 2014 May; 57(6):425-33. PubMed ID: 24889134
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel-loaded ethosomes®: potential treatment of squamous cell carcinoma, a malignant transformation of actinic keratoses.
Paolino D; Celia C; Trapasso E; Cilurzo F; Fresta M
Eur J Pharm Biopharm; 2012 May; 81(1):102-12. PubMed ID: 22414731
[TBL] [Abstract][Full Text] [Related]
10. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable polymer-mediated intratumoral delivery of cisplatin for treatment of human head and neck squamous cell carcinoma in a chimeric mouse model.
Chen FA; Kuriakose MA; Zhou MX; DeLacure MD; Dunn RL
Head Neck; 2003 Jul; 25(7):554-60. PubMed ID: 12808659
[TBL] [Abstract][Full Text] [Related]
12. Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy.
Matsushita S; Kawai K; Tada K; Mera K; Kubo H; Ibusuki A; Yoshii N; Kanekura T
J Dermatol; 2010 Jul; 37(7):666-70. PubMed ID: 20629834
[TBL] [Abstract][Full Text] [Related]
13. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.
Yu NY; Patawaran MB; Chen JY; Orenberg EK; Brown DM; Luck EE
Cancer J Sci Am; 1995; 1(3):215-21. PubMed ID: 9166479
[TBL] [Abstract][Full Text] [Related]
14. Effects of intralesional versus ip administration of cisplatin on squamous cell carcinoma of mice.
Nagase M; Nomura T; Nakajima T
Cancer Treat Rep; 1987 Sep; 71(9):825-9. PubMed ID: 3621215
[TBL] [Abstract][Full Text] [Related]
15. [Significance of formation of micronuclei in SCC VII murine cells treated with various chemotherapeutic agents].
Jeremić B; Sibamoto J; Abe M
Srp Arh Celok Lek; 1996; 124(7-8):169-74. PubMed ID: 9102841
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intratumoral administration of cisplatin versus bleomycin for treatment of periocular squamous cell carcinomas in horses.
Théon AP; Pascoe JR; Madigan JE; Carlson G; Metzger L
Am J Vet Res; 1997 Apr; 58(4):431-6. PubMed ID: 9099393
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system.
Light BW; Yu WD; McElwain MC; Russell DM; Trump DL; Johnson CS
Cancer Res; 1997 Sep; 57(17):3759-64. PubMed ID: 9288784
[TBL] [Abstract][Full Text] [Related]
18. Comparison of perioperative versus postoperative intratumoral administration of cisplatin for treatment of cutaneous sarcoids and squamous cell carcinomas in horses.
Théon AP; Pascoe JR; Galuppo LD; Fisher PE; Griffey SM; Madigan JE
J Am Vet Med Assoc; 1999 Dec; 215(11):1655-60. PubMed ID: 14567430
[TBL] [Abstract][Full Text] [Related]
19. Comparative intravenous toxicity of cisplatin solution and cisplatin encapsulated in long-circulating, pegylated liposomes in cynomolgus monkeys.
Working PK; Newman MS; Sullivan T; Brunner M; Podell M; Sahenk Z; Turner N
Toxicol Sci; 1998 Nov; 46(1):155-65. PubMed ID: 9928679
[TBL] [Abstract][Full Text] [Related]
20. Marked and restricted cutaneous pigmentation induced by selective intra-arterial cisplatin infusion.
Yanagi T; Akiyama M; Aoyagi S; Shibaki A; Homma A; Shimizu H
J Am Acad Dermatol; 2006 Feb; 54(2):362-3. PubMed ID: 16443080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
